AR043332A1 - Composiciones y metodos para terapia antiviral - Google Patents
Composiciones y metodos para terapia antiviralInfo
- Publication number
- AR043332A1 AR043332A1 ARP040100088A AR043332A1 AR 043332 A1 AR043332 A1 AR 043332A1 AR P040100088 A ARP040100088 A AR P040100088A AR 043332 A1 AR043332 A1 AR 043332A1
- Authority
- AR
- Argentina
- Prior art keywords
- combinations
- methods
- compositions
- emtricitabine
- formulations
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 3
- 238000000034 method Methods 0.000 title abstract 2
- 230000000840 anti-viral effect Effects 0.000 title 1
- 238000002560 therapeutic procedure Methods 0.000 title 1
- XQSPYNMVSIKCOC-NTSWFWBYSA-N Emtricitabine Chemical compound C1=C(F)C(N)=NC(=O)N1[C@H]1O[C@@H](CO)SC1 XQSPYNMVSIKCOC-NTSWFWBYSA-N 0.000 abstract 3
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 abstract 2
- 229960000366 emtricitabine Drugs 0.000 abstract 2
- 238000009472 formulation Methods 0.000 abstract 2
- 239000002777 nucleoside Substances 0.000 abstract 2
- 150000003833 nucleoside derivatives Chemical class 0.000 abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 abstract 2
- LDEKQSIMHVQZJK-CAQYMETFSA-N tenofovir alafenamide Chemical compound O([P@@](=O)(CO[C@H](C)CN1C2=NC=NC(N)=C2N=C1)N[C@@H](C)C(=O)OC(C)C)C1=CC=CC=C1 LDEKQSIMHVQZJK-CAQYMETFSA-N 0.000 abstract 2
- 230000001225 therapeutic effect Effects 0.000 abstract 2
- 229930024421 Adenine Natural products 0.000 abstract 1
- 208000031886 HIV Infections Diseases 0.000 abstract 1
- 229960000643 adenine Drugs 0.000 abstract 1
- 239000003443 antiviral agent Substances 0.000 abstract 1
- 229940001018 emtriva Drugs 0.000 abstract 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 abstract 1
- LLYJISDUHFXOHK-GOCONZMPSA-N ferroptocide Chemical compound C[C@@H]1CC[C@@]23C[C@@H](C(=O)[C@]2([C@@]1([C@@H](C[C@H]([C@@H]3C)C4=CCN5C(=O)N(C(=O)N5C4)C6=CC=CC=C6)OC(=O)CCl)C)O)O LLYJISDUHFXOHK-GOCONZMPSA-N 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 125000005928 isopropyloxycarbonyl group Chemical group [H]C([H])([H])C([H])(OC(*)=O)C([H])([H])[H] 0.000 abstract 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 abstract 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Combinaciones terapéuticas de [9-[R-2-[[(S)-1-(isopropoxicarbonil)etil]amino-fenoxifosfinil]metoxi]propil]adenina (GS-7340) y (2R, 5S, cis)-4-amino-5-fluoro-1-(2-hidroximetil-1,3-oxatiolan-5-il)-(1H)-pirimidin-2-ona (emtricitabina, (-)-cis FTC, Emtriva [marca]) y sus derivados fisiológicamente funcionales y opcionalmente un tercer agente antiviral. Las combinaciones pueden ser útiles en el tratamiento de infecciones de HIV, incluyendo infecciones con mutantes de HIV resistentes a inhibidores de nucleósido o de nucleósido. Composiciones farmacéuticas y formulaciones de dichas combinaciones de GS-7340 y emtricitabina, y sus derivados fisiológicamente funcionales, y métodos de uso terapéutico de esas composiciones y formulaciones.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US44030803P | 2003-01-14 | 2003-01-14 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR043332A1 true AR043332A1 (es) | 2005-07-27 |
Family
ID=36081149
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP040100088 AR043332A1 (es) | 2003-01-14 | 2004-01-14 | Composiciones y metodos para terapia antiviral |
Country Status (4)
| Country | Link |
|---|---|
| CN (1) | CN1738628B (es) |
| AR (1) | AR043332A1 (es) |
| TW (1) | TW200425895A (es) |
| ZA (1) | ZA200505852B (es) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102198110B (zh) * | 2011-05-27 | 2012-11-14 | 杭州科本药业有限公司 | 富马酸替诺福韦二吡呋酯分散片及其制备方法 |
| CN103127028A (zh) * | 2013-03-14 | 2013-06-05 | 南京恒道医药科技有限公司 | 一种含有富马酸替诺福韦二吡呋酯的胶囊剂 |
| CN106539807B (zh) * | 2015-09-21 | 2020-06-26 | 四川海思科制药有限公司 | 一种稳定的药物组合物及其制备方法 |
| CN110251476B (zh) * | 2019-08-01 | 2022-08-09 | 海思科制药(眉山)有限公司 | 一种恩曲他滨替诺福韦药物组合物 |
| CN112274488B (zh) * | 2020-10-22 | 2022-08-26 | 安徽贝克生物制药有限公司 | 一种恩曲他滨、替诺福韦复方片及其制备方法 |
| CN116178292A (zh) * | 2022-05-20 | 2023-05-30 | 吴卫东 | 氟烷基和氮杂基团取代的核苷类似物前体及其合成方法和医学用途 |
-
2004
- 2004-01-13 CN CN200480002190.5A patent/CN1738628B/zh not_active Ceased
- 2004-01-13 TW TW93100811A patent/TW200425895A/zh unknown
- 2004-01-14 AR ARP040100088 patent/AR043332A1/es unknown
-
2005
- 2005-07-21 ZA ZA200505852A patent/ZA200505852B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ZA200505852B (en) | 2006-05-31 |
| CN1738628B (zh) | 2012-06-06 |
| TW200425895A (en) | 2004-12-01 |
| CN1738628A (zh) | 2006-02-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20053817L (no) | Preparater og fremgangsmater for antiviral kombinasjonsterapi. | |
| GEP20022647B (en) | Synergistic Combinations | |
| UY27875A1 (es) | Prodrogas 2 ' y 3 ' de nucleósidos modificados para tratar flaviviridae | |
| TW366347B (en) | Antiviral pharmaceutical compositions comprising 1,3-oxathiolane nucleoside analogues | |
| DK1658302T3 (da) | Purinnukleosidanaloge til behandling af sygdomme forårsaget af Flavirividae, herunder hepatitis C | |
| RU94013464A (ru) | Нуклеозидные аналоги 1,3-оксатиолана, способ получения, фармацевтическая композиция, способ лечения вирусной инфекции | |
| MY109796A (en) | 1,3-oxathiolane nucleoside analogues. | |
| NZ601486A (en) | 2',4'-substituted nucleosides as antiviral agents | |
| PA8588501A1 (es) | Derivados antivirales de nucleósidos | |
| EA200970273A1 (ru) | Применение 2-6-(3-аминопиперидин-1-ил)-3-метил-2,4-диоксо-3,4-дигидро-2н-пиримидин-1-илметил-4-фторбензонитрила | |
| DK1259240T3 (da) | Midler, såsom nikotinamid eller CADPR, til behandling af hudsygdomme | |
| CL2007001748A1 (es) | Compuesto derivado de 2-arilamino-4-aminopirimidinas, inhibidores de la proteina quinasa c-alfa; composiciones farmaceuticas que los contienen; y su uso para tratar o prevenir la diabetes, el cancer, enfermedades cardiovasculares y otras. | |
| NZ590075A (en) | citrate, malonate and succinate salts of the HIV inhibitor ethyl N-[(S)({ [(2R,5R)-5-(6-amino-9H-purin-9-yl)-4-fluoro-2,5-dihydrofuran-2-yl]oxy} methyl)phenoxyphosphinoyl]-L-alaninate | |
| MX2007004749A (es) | Uso de agosnitas de receptor a2a de adenosina. | |
| AR043332A1 (es) | Composiciones y metodos para terapia antiviral | |
| AR023661A1 (es) | Combinaciones antivirales | |
| WO2005023270A3 (en) | Compositions and methods for use of antiviral drugs in the treatment of retroviral diseases resistant to nucleoside reverse transcriptase inhibitors | |
| AR040242A1 (es) | Composiciones farmaceuticas | |
| AR040805A1 (es) | Composiciones que contienen tenofovir y emtricitabina y metodos para terapia antiviral | |
| AR026255A1 (es) | Combinaciones antivirales. | |
| NZ601519A (en) | COMPOSITIONS AND METHODS FOR TREATING HEPATITIS B VIRUS INFECTION comprising lamivudine and adefovir dipivoxil | |
| PT1259229E (pt) | Utilizacao de benzotieno-[2,3-d]-pirimidinas com uma accao inibidora da pde v no tratamento do disfuncao erectil | |
| MD2671G2 (ro) | Remediu medicamentos antivirotic şi antiherpetic sub formă de gel | |
| WO2000018383A3 (en) | Antiviral combinations comprising (s)-2- ethyl-7- fluoro-3- oxo-3,4- dihydro-2h- quinoxaline-1- carboxylic acid isopropyl ester | |
| AR120453A1 (es) | Combinación de un inhibidor de btk y un inhibidor de mdm2 para el tratamiento del cáncer |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |